⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL2642702 | 0.97 | CRBN (0.42) | — | |
| Glycine SCHEMBL2192780 | 0.87 | GLRA1 (0.40) | — | |
| Succinic Acid SCHEMBL7644469 | 0.87 | PHF8 (0.41) | — | |
| Metformin SCHEMBL4410446 | 0.78 | CRBN (0.33) | — | |
| Metformin SCHEMBL4364474 | 0.78 | LMNA (0.30) | — | |
| Metformin SCHEMBL1323029 | 0.78 | CRBN (0.33) | — | |
| Metformin SCHEMBL8944 | 0.78 | — | — | |
| Metformin SCHEMBL1766280 | 0.78 | LMNA (0.36) | — | |
| Metformin SCHEMBL28844380 | 0.77 | — | — | |
| Metformin SCHEMBL3688836 | 0.77 | HTT (0.32) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 411 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240029844-A1 | METHODS FOR LOWERING BLOOD SUGAR WITH A METFORMIN PHARMACEUTICAL COMPOSITION | ASTRAZENECA UK LIMITED (GB) | 2024-01-25 | — | — | US | claimed |
| US-20230364037-A1 | CANCER THERAPEUTIC | GILLIES MCINDOE RESEARCH INSTITUTE (NZ) | 2023-11-16 | — | — | US | claimed |
| EP-4218819-A2 | COMBINATION THERAPY BASED ON PD-1 SIGNAL INHIBITORS | Kyoto University (JP) | 2023-08-02 | — | — | EP | claimed |
| US-11547699-B2 | [2-[(5-nitro-1,3-thiazol-2-yl)carbamoyl]phenyl]ethanoate for use in lymphangioleiomyomatosis and other diseases | KOESTER HUBERT (DE) | 2023-01-10 | — | — | US | claimed |
| US-20210369682-A1 | [2-[(5-NITRO-1,3-THIAZOL-2-YL)CARBAMOYL]PHENYL]ETHANOATE FOR USE IN LYMPHANGIOLEIOMYOMATOSIS AND OTHER DISEASES | KOESTER HUBERT (DE) | 2021-12-02 | — | — | US | claimed |
| EP-3807895-A1 | METHODS FOR LOWERING BLOOD SUGAR WITH A METFORMIN PHARMACEUTICAL COMPOSITION | AstraZeneca UK Limited (GB) | 2021-04-21 | — | — | EP | claimed |
| US-20200197335-A1 | CANCER THERAPEUTIC | GILLIES MCINDOE RESEARCH INSTITUTE (NZ) | 2020-06-25 | — | — | US | claimed |
| US-20180362650-A1 | PD-1 SIGNAL INHIBITOR COMBINATION THERAPY | KYOTO UNIVERSITY (JP) | 2018-12-20 | — | — | US | claimed |
| EP-3388084-A1 | PD-1 SIGNAL INHIBITOR COMBINATION THERAPY | Kyoto University (JP) | 2018-10-17 | — | — | EP | claimed |
| WO-2018143826-A1 | CANCER THERAPEUTIC | GILLIES MCINDOE RESEARCH INSTITUTE (NZ) | 2018-08-09 | — | — | WO | claimed |
| US-20050136017-A1 | Cosmetic containing an imine reactive with the cystines of keratin fibers via a beta-elimination reaction to produce dehydroalanine and lead to formation of lanthionine in a medium free of polyhydroxylated alkane; guanidine and/or amidine imines such as dimethylguanidine; noncaustic for use on hair, skin | L'OREAL S.A. (FR) | 2005-06-23 | — | — | US | claimed |
| US-20050129645-A1 | Hair shaping composition comprising at least one non-hydroxide imine | L'OREAL | 2005-06-16 | — | — | US | claimed |
| EP-1532963-A1 | Composition for straightening the hair comprising at least one imine not being an hydroxide | L'OREAL (FR) | 2005-05-25 | — | — | EP | claimed |
| EP-1532960-A1 | Hair styling composition containing a non-hydroxide imine | L'OREAL (FR) | 2005-05-25 | — | — | EP | claimed |
| WO-2005033089-A1 | SALT OF 6-(1, 3-DIHYDRO-4-HYDROXY-6-METHOXY-7-METHYL-3-OXO-5-ISOBENZOFURANYL)-4-METHYL-4-HEXENOIC ACID WITH N, N-DIMETHYL-IMIDODICARBONIMIDIC DIAMIDE | BIOCON LIMITED (IN) | 2005-04-14 | — | — | WO | claimed |
| WO-2005033067-A1 | SALT OF 1,2,6,7,8,8A-HEXAHYDRO-β,δ,6-TRIHYDROXY-2-METHYL-8-[(2S)-2-METHYL-1-OXOBUTOXY]-, (βR,δ R,1S,2S,6S,8S,8AR)- 1-NAPHTHALENEHEPTANOIC ACID WITH N,N-DIMETHYL-IMIDODICARBONIMIDIC DIAMIDE | BIOCON LIMITED (IN) | 2005-04-14 | — | — | WO | claimed |
| US-20030219440-A1 | 3-deoxyglucosone and skin | DYNAMIS THERAPEUTICS, INC. | 2003-11-27 | — | — | US | claimed |
| WO-2002012177-A1 | COMPOSITION OF METFORMIN WITH SUCCINIC ACID OR SALTS THEREOF AND METHOD FOR TREATING DIABETES | POMYTKIN IGOR ANATOLIEVICH (RU) | 2002-02-14 | — | — | WO | claimed |
| WO-1992007560-A1 | BIGUANIDES AND DERIVATIVES THEREOF AS INHIBITORS OF ADVANCED GLYCOSYLATION OF A TARGET PROTEIN | THE ROCKEFELLER UNIVERSITY (US) | 1992-05-14 | — | — | WO | claimed |
| US-5100919-A | Aging resistance; food preservatives | THE ROCKEFELLER UNIVERSITY (US) | 1992-03-31 | — | — | US | claimed |